Johns Hopkins University describes an NIH-funded platform combining brain organoids, sensors, and AI to improve drug discovery and reduce animal testing. It signals AI being embedded into experimental pipelines, not just analytics.
Johns Hopkins researchers have been awarded $15M from the @NIH to develop a new platform for studying neurological diseases.
By combining brain organoids, advanced sensors, and AI, the project aims to improve drug discovery and reduce reliance on animal testing.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare